-
effectivehealthcare-admin.ahrq.gov/products/medication-therapy-management/research-protocol
December 01, 2019 - Background and Objectives for the Systematic Review
The Medicare Prescription Drug … individual patients that are independent of, but can occur in conjunction with, the provision of a drug … substitution issue; complex regimen that can be simplified with same therapeutic benefit; and potential for drug-drug … : needed drug initiated; unnecessary drug discontinued; change in drug dose, form, or frequency; or generic … Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Public Law 108-173.
-
effectivehealthcare-admin.ahrq.gov/health-topics/opioid-abuse-and-addiction
April 01, 2021 - Opioid Abuse and Addiction
Description
Opioids, sometimes called narcotics, are a type of drug … The illegal drug heroin is also an opioid. … Dependence means feeling withdrawal symptoms when not taking the drug. … MAT can help you stop using the drug, get through withdrawal, and cope with cravings. … NIH: National Institute on Drug Abuse
Source
https://medlineplus.gov/opioidabuseandaddiction.html
-
effectivehealthcare-admin.ahrq.gov/products/deprescribing-mhs4/rapid-research
February 01, 2024 - Few adverse drug withdrawal events resulted from deprescribing interventions. … Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug … | Sep 7, 2023
Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug … Healthcare Safer IV: Opioid Stewardship
Rapid Evidence Product | Jan 16, 2024
Reducing Adverse Drug … | Feb 9, 2024
Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug
-
effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric/research
December 01, 2019 - EHC FAQs
Home
Evidence Reports
Drug … Report
SHARE:
Drug … participants, and relevant good- or fair-quality meta-analyses that compared benefits or harms of 14 drug … Literature was synthesized qualitatively within and between the two main drug classes (oral and biologic … Project Timeline
Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report
Aug 17
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
September 20, 2022 - Harms of tricyclic antidepressants versus placebo
Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo
Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin versus amitriptyline
Author, Year Quality Pain Population Drug Class Drug Assessment … Harms of pregabalin CR versus IR
Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo
Author, Year Quality Pain Population Drug Assessment Time (Wk) Time
-
effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/consumer
January 01, 2021 - Food and Drug Administration (FDA) to treat alcohol dependence*. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/consumer
-
effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/policymaker
January 01, 2021 - Food and Drug Administration for AUD include acamprosate (Campral ® , thrice daily), disulfiram (Antabuse … Food and Drug Administration as treatment for alcohol dependence, alcohol abuse, or AUD. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/policymaker
-
effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/research
January 01, 2021 - Food and Drug Administration Web site, ClinicalTrials.gov, and World Health Organization International … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/research
-
effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/espanol
January 01, 2021 - Acamprosato (Campral®) : Este medicamento fue aprobado por la Food and Drug Administration (FDA, por … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/espanol
-
effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician
January 01, 2021 - Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician
-
effectivehealthcare-admin.ahrq.gov/products/bipolar-disorder-treatment/final-report-2018
December 01, 2019 - Depression treatment: Evidence was insufficient for drug treatments for depressive episodes in adults … Assess the effect of drug and nondrug interventions for treating acute symptoms associated with bipolar … All drug study findings with at least low-strength evidence were based almost exclusively on adults with … All other drug comparisons to placebo or active controls for acute mania, depression, and maintenance … All antipsychotics approved by the Food and Drug Administration, except aripiprazole, had low-strength
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
May 01, 2009 - and drug interactions. … Food and Drug Administration, Center for
Drug Evaluation and Review. … /Drug Safety
Diane Kennedy, RPh, MPH Food and Drug Administration Regulator/Drug Analysis
Laurie … has serious side effects.**
2) The drug has frequent side effects.
3) The drug has serious drug-drug … interactions.**
4) The drug has frequent drug-drug interactions.*
5) The drug is approved in other
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
September 20, 2022 - Harms of tricyclic antidepressants versus placebo
Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo
Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin versus amitriptyline
Author, Year Quality Pain Population Drug Class Drug Assessment … Harms of pregabalin CR versus IR
Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of naproxen versus placebo
Author, Year Quality Pain Population Drug Class Drug Assessment Time
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
September 13, 2024 - Food and Drug Administration (FDA) has commissioned a rapid review on the
misuse of attention-deficit … The National Institute on Drug Abuse (NIDA) describes misuse
as: “taking a medication in a manner or … Drug Alcohol Depend.
2020 Apr 1;209:107907. doi: 10.1016/j.drugalcdep.2020.107907. … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug
Diversion"[Mesh] OR "Substance Abuse, Oral … Misuse"[Mesh]
OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance
Abuse, Oral
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s96.pdf
October 01, 2007 - Key Words: adverse drug reaction reporting systems,
surveillance, drug safety
(Med Care 2007;45: S96 … –S102)
An adverse drug event (ADE) occurs when a drug intendedfor therapeutic use has an unintended … or a drug-specific
effect. … How the US Food and Drug Administration defines and
detects adverse drug events. … Incidence of adverse drug events
and potential adverse drug events. Implications for prevention.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
July 01, 2012 - events) and real (adverse drug events being a subset of the drug
related problems) drug related problems … events, and assess medication
appropriateness, potential drug-drug and drug-food interactions, dose … drug related problems. … The patient is having an adverse
drug event (ADE) as a result of the drug.
a. … Does the patient have an allergy to the drug or
similar drug? (7.1)
b.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s9.pdf
October 01, 2007 - drug subsidy. … Coverage for the prescription drug benefit is provided
under various types of prescription drug plans … ) prescription drug
plans (MA-PDPs), which offer prescription drug coverage
that is integrated with the … Medicare Part D Prescription Drug Event (PDE) Data. … Total Medicare Beneficiaries With Drug Coverage
as of June 11, 2006
Description
June
(Millions)
Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s13.pdf
October 01, 2007 - , or the drug indication itself. … to prove drug efficacy (ie, the possibility of a
beneficial effect in an ideal setting), but not drug … effec-
tiveness (ie, whether the drug works in reality).3 Further,
information on comparative drug effectiveness … type, how long the drug has been
taken, how recently the drug was taken, and demographics of
the patient … US Food and Drug Administration.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-9_maps.pdf
March 29, 2012 - 2009
Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Insulin Among Diabetic Beneficiaries With At Least One Antidiabetic Drug
-
effectivehealthcare-admin.ahrq.gov/products/dietary-supplements/research-protocol
December 01, 2019 - and Drug-Dietary Supplement Interactions: In the clinical setting, drug-supplement interactions are … more difficult to interpret than drug-drug interactions for a variety of reasons. … Due to U.S. drug regulatory policy, much more research and data are available describing drug-drug interactions … than drug-supplement interactions, and there is a clear need to synthesize information on drug-supplement … . . .cause alterations in cellular drug-transport mechanisms (e.g., drug-transport proteins)?